ask="11.98"
ask_size="100"
average_daily_volume="58427"
bid="5.50"
bid_size="500"
book_value="-19.19"
change="+0.41"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="0.22"
change_from_52_week_high="-12.67"
change_From_52_week_low="1.26"
change_in_percent="+5.91%"
close="7.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.44"
high_52_weeks="20.02"
last_trade_date="2/2/2017"
last_trade_price="7.35"
last_trade_size="168"
last_trade_time="3:55pm"
low="6.76"
low_52_weeks="6.09"
market_capitalization="17.91M"
moving_average_200_day="7.30"
moving_average_50_day="7.13"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="6.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.72%"
percent_change_from_50_day_moving_average="+3.12%"
percent_change_from_52_week_high="-63.29%"
percent_change_from_52_week_low="+20.69%"
previous_close="6.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.54"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="1.08"
stock_exchange="NGM"
symbol="KALV"
volume="56804"
weeks_range_52="6.09 - 20.02"
